Annual Working Capital
$6.42 M
+$2.40 M+59.69%
December 31, 2023
Summary
- As of February 7, 2025, BGLC annual working capital is $6.42 million, with the most recent change of +$2.40 million (+59.69%) on December 31, 2023.
- During the last 3 years, BGLC annual working capital has risen by +$1.80 million (+39.12%).
- BGLC annual working capital is now at all-time high.
Performance
BGLC Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$5.62 M
-$818.90 K-12.71%
September 30, 2024
Summary
- As of February 7, 2025, BGLC quarterly working capital is $5.62 million, with the most recent change of -$818.90 thousand (-12.71%) on September 30, 2024.
- Over the past year, BGLC quarterly working capital has dropped by -$818.90 thousand (-12.71%).
- BGLC quarterly working capital is now -15.11% below its all-time high of $6.63 million, reached on September 30, 2023.
Performance
BGLC Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
BGLC Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +59.7% | -12.7% |
| 3 y3 years | +39.1% | +44.4% |
| 5 y5 years | +419.3% | +44.4% |
BGLC Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +59.7% | -15.1% | +67.9% |
| 5 y | 5-year | at high | +672.1% | -15.1% | +724.6% |
| alltime | all time | at high | +672.1% | -15.1% | +724.6% |
BioNexus Gene Lab Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.62 M(-12.7%) |
| Jun 2024 | - | $6.44 M(+4.1%) |
| Mar 2024 | - | $6.19 M(-3.5%) |
| Dec 2023 | $6.42 M(+59.7%) | $6.42 M(-3.2%) |
| Sep 2023 | - | $6.63 M(+97.8%) |
| Jun 2023 | - | $3.35 M(-14.0%) |
| Mar 2023 | - | $3.90 M(-3.0%) |
| Dec 2022 | $4.02 M(-16.7%) | $4.02 M(-1.4%) |
| Sep 2022 | - | $4.07 M(-4.4%) |
| Jun 2022 | - | $4.26 M(-7.6%) |
| Mar 2022 | - | $4.62 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $4.82 M(+4.5%) | - |
| Dec 2021 | - | $4.82 M(+1.8%) |
| Sep 2021 | - | $4.74 M(+4.7%) |
| Jun 2021 | - | $4.52 M(-0.1%) |
| Mar 2021 | - | $4.53 M(-1.8%) |
| Dec 2020 | $4.61 M(+455.0%) | $4.61 M(+576.1%) |
| Sep 2020 | - | $682.10 K(-4.8%) |
| Jun 2020 | - | $716.30 K(-5.8%) |
| Mar 2020 | - | $760.70 K(-8.5%) |
| Dec 2019 | $831.00 K(-32.7%) | $831.00 K |
| Dec 2018 | $1.24 M | - |
FAQ
- What is BioNexus Gene Lab annual working capital?
- What is the all time high annual working capital for BioNexus Gene Lab?
- What is BioNexus Gene Lab annual working capital year-on-year change?
- What is BioNexus Gene Lab quarterly working capital?
- What is the all time high quarterly working capital for BioNexus Gene Lab?
- What is BioNexus Gene Lab quarterly working capital year-on-year change?
What is BioNexus Gene Lab annual working capital?
The current annual working capital of BGLC is $6.42 M
What is the all time high annual working capital for BioNexus Gene Lab?
BioNexus Gene Lab all-time high annual working capital is $6.42 M
What is BioNexus Gene Lab annual working capital year-on-year change?
Over the past year, BGLC annual working capital has changed by +$2.40 M (+59.69%)
What is BioNexus Gene Lab quarterly working capital?
The current quarterly working capital of BGLC is $5.62 M
What is the all time high quarterly working capital for BioNexus Gene Lab?
BioNexus Gene Lab all-time high quarterly working capital is $6.63 M
What is BioNexus Gene Lab quarterly working capital year-on-year change?
Over the past year, BGLC quarterly working capital has changed by -$818.90 K (-12.71%)